UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Reply to Cailes et al

The American journal of gastroenterology, 2023-01, Vol.118 (1), p.180-181

2023

Volltextzugriff (PDF)

Cirrhotic cardiomyopathy: pathogenesis and clinical relevance

Nature reviews. Gastroenterology & hepatology, 2014-03, Vol.11 (3), p.177-186

2014

Volltextzugriff (PDF)

Cardiovascular Mapping in Cirrhosis From the Compensated Stage to Hepatorenal Syndrome: A Magnetic Resonance Study

The American journal of gastroenterology, 2022-08, Vol.117 (8), p.1269-1278

2022

Volltextzugriff (PDF)

How non-alcoholic fatty liver disease and cirrhosis affect the heart

Hepatology international, 2023-12, Vol.17 (6), p.1333-1349

2023

Volltextzugriff (PDF)

Myocardial extracellular volume quantified by magnetic resonance is increased in cirrhosis and related to poor outcome

Liver international, 2018-09, Vol.38 (9), p.1614-1623

2018

Volltextzugriff (PDF)

Association of low mechano-energitic efficiency and prognosis in liver cirrhosis

Journal of hepatology, 2022-07, Vol.77, p.S614

2022

Volltextzugriff (PDF)

Cardiac dysfunction in patients with cirrhosis and acute decompensation

Liver international, 2024-08, Vol.44 (8), p.1832-1841

2024

Volltextzugriff (PDF)

Bile acids and cardiovascular function in cirrhosis

Liver international, 2017-10, Vol.37 (10), p.1420-1430

2017

Volltextzugriff (PDF)

The composition of the bile acid pool is closely associated with fibrosis in the heart and liver of patients with cirrhosis

Journal of hepatology, 2022-07, Vol.77, p.S887

2022

Volltextzugriff (PDF)

WED-331-YI Subclinical myocardial fibrosis is related to disease severity in patients with metabolic dysfunction-associated steatotic liver disease (MASLD)

Journal of hepatology, 2024-06, Vol.80, p.S555-S555

2024

Volltextzugriff (PDF)

Renal and circulatory effects of terlipressin in patients with hepatorenal syndrome assessed by magnetic resonance imaging

Journal of hepatology, 2022-07, Vol.77, p.S340-S341

2022

Volltextzugriff (PDF)

Peptidylglycine alpha-amidating monooxygenase and adrenomedullin measurements suggest cardio-circulatory dysfunction in advanced cirrhosis

Journal of hepatology, 2022-07, Vol.77, p.S361-S362

2022

Volltextzugriff (PDF)

SAT218 - Increased levels of soluble mannose receptor are associated with poor outcome in cirrhosis: results from a 2-year longitudinal study

Journal of hepatology, 2020-08, Vol.73, p.S762-S762

2020

Volltextzugriff (PDF)

Increased levels of soluble mannose receptor are associated with poor outcome in cirrhosis: results from a 2-year longitudinal study

Journal of hepatology, 2020-08, Vol.73, p.S762

2020

Volltextzugriff (PDF)

Association of low mechano‐energetic efficiency and prognosis in liver cirrhosis

Clinical physiology and functional imaging, 2023-01, Vol.43 (1), p.28-32

2023

Volltextzugriff (PDF)

Low ascitic fluid total protein levels is not associated to the development of spontaneous bacterial peritonitis in a cohort of 274 patients with cirrhosis

Scandinavian journal of gastroenterology, 2018-02, Vol.53 (2), p.200-205

2018

Volltextzugriff (PDF)

Altered serum bile acid composition is associated with cardiac dysfunction in cirrhosis

Alimentary pharmacology & therapeutics, 2023-08, Vol.58 (4), p.453-462

2023

Volltextzugriff (PDF)

Effect of beta-blockers on multiple haemodynamics in cirrhosis: A cross-over study by MR-imaging and hepatic vein catheterization

Liver international, 2023-10, Vol.43 (10), p.2245-2255

2023

Volltextzugriff (PDF)

An update on cirrhotic cardiomyopathy

Expert review of gastroenterology & hepatology, 2019-05, Vol.13 (5), p.497-505

2019

Volltextzugriff (PDF)

SAT-138-Cirrhotic cardiomyopathy: A 2-year longitudinal follow-up study using advanced cardiac imaging

Journal of hepatology, 2019-04, Vol.70 (1), p.e691-e691

2019

Volltextzugriff (PDF)

FRI-130-Changes in the extracellular matrix of the heart and the liver assessed by MRI with T1-mapping are closely linked in cirrhosis: Is inflammation the shared pathway?

Journal of hepatology, 2019-04, Vol.70 (1), p.e444-e445

2019

Volltextzugriff (PDF)

Dipeptidyl peptidase-3 is associated with severity of liver disease and circulatory complications in patients with cirrhosis

Biomarkers, 2022-02, Vol.27 (2), p.196-204

2022

Volltextzugriff (PDF)

Pronounced Coronary Arteriosclerosis in Cirrhosis: Influence on Cardiac Function and Survival?

Digestive diseases and sciences, 2018-05, Vol.63 (5), p.1355-1362

2018

Volltextzugriff (PDF)

Diastolic dysfunction in cirrhosis

Heart failure reviews, 2016-09, Vol.21 (5), p.599-610

2016

Volltextzugriff (PDF)

Cardiac and proinflammatory markers predict prognosis in cirrhosis

Liver international, 2014-07, Vol.34 (6), p.e19-e30

2014

Volltextzugriff (PDF)

1 – 25 von 47

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(46)
Buchkapitel
(1)

Sprache

Englisch
(47)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Reply to Cailes et al

Cirrhotic cardiomyopathy: pathogenesis and clinical relevance

Cardiovascular Mapping in Cirrhosis From the Compensated Stage to Hepatorenal Syndrome: A Magnetic Resonance Study

How non-alcoholic fatty liver disease and cirrhosis affect the heart

Myocardial extracellular volume quantified by magnetic resonance is increased in cirrhosis and related to poor outcome

Association of low mechano-energitic efficiency and prognosis in liver cirrhosis

Cardiac dysfunction in patients with cirrhosis and acute decompensation

Bile acids and cardiovascular function in cirrhosis

The composition of the bile acid pool is closely associated with fibrosis in the heart and liver of patients with cirrhosis

WED-331-YI Subclinical myocardial fibrosis is related to disease severity in patients with metabolic dysfunction-associated steatotic liver disease (MASLD)

Renal and circulatory effects of terlipressin in patients with hepatorenal syndrome assessed by magnetic resonance imaging

Peptidylglycine alpha-amidating monooxygenase and adrenomedullin measurements suggest cardio-circulatory dysfunction in advanced cirrhosis

SAT218 - Increased levels of soluble mannose receptor are associated with poor outcome in cirrhosis: results from a 2-year longitudinal study

Increased levels of soluble mannose receptor are associated with poor outcome in cirrhosis: results from a 2-year longitudinal study

Association of low mechano‐energetic efficiency and prognosis in liver cirrhosis

Low ascitic fluid total protein levels is not associated to the development of spontaneous bacterial peritonitis in a cohort of 274 patients with cirrhosis

Altered serum bile acid composition is associated with cardiac dysfunction in cirrhosis

Effect of beta-blockers on multiple haemodynamics in cirrhosis: A cross-over study by MR-imaging and hepatic vein catheterization

An update on cirrhotic cardiomyopathy

SAT-138-Cirrhotic cardiomyopathy: A 2-year longitudinal follow-up study using advanced cardiac imaging

FRI-130-Changes in the extracellular matrix of the heart and the liver assessed by MRI with T1-mapping are closely linked in cirrhosis: Is inflammation the shared pathway?

Dipeptidyl peptidase-3 is associated with severity of liver disease and circulatory complications in patients with cirrhosis

Pronounced Coronary Arteriosclerosis in Cirrhosis: Influence on Cardiac Function and Survival?

Diastolic dysfunction in cirrhosis

Cardiac and proinflammatory markers predict prognosis in cirrhosis

Suchergebnisse filtern